PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. (Q42991808)
Jump to navigation
Jump to search
scientific article published in September 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. |
scientific article published in September 2010 |
Statements
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma (English)
J R Perry
J A Julian
W Geerts
G Agnelli
L R Rogers
M G Malkin
R Sawaya
R Baker
S Parpia
T Finch
1 September 2010
1 reference
1 reference